Search results
Results from the WOW.Com Content Network
The International Society of Blood Transfusion (ISBT) working group on automation and data processing began in the early 1990s and was later joined by the AABB, the American Red Cross (ARC), the US Department of Defense, [1] and the Health Industry Manufacturers Association in the development of the symbology which would come to be known as the ISBT 128 international standard.
One outcome of this work, the "Guide to the preparation, use and quality assurance of blood components", [28] provides recommendations on blood collection, blood components, technical procedures, transfusion practices and quality systems for BEs. Through its Blood Proficiency Testing Scheme [29] and Blood Quality Management Programme [30] the ...
To ensure the safety of blood components, regimented procedures and quality assurance systems must be in place covering all aspects of the transfusion chain, from donation to transfusion outcomes. Within hospitals, transfusion committees are established to ensure safe hospital transfusion practice such as compliance with standards and ...
Before a blood transfusion is given, there are many steps taken to ensure quality of the blood products, compatibility, and safety to the recipient. In 2012, a national blood policy was in place in 70% of countries and 69% of countries had specific legislation that covers the safety and quality of blood transfusion. [10]
Blood banks were created, voluntary blood donations came in great numbers in the allied nations, plasma-transfusion became a standard anti-shock treatment, Rh and Kell systems were discovered, and industrial blood plasma fractionation was developed to produce albumin, which can be used as a substitute for plasma.
The AABB conducts assessments every two years of institutional member facilities that procure, process, store and/or distribute cellular therapy products to ensure they meet the association’s voluntary standards, including hematopoietic progenitor cell, umbilical cord blood stem cell, somatic cell product and clinical services facilities in ...
The term human blood group systems is defined by the International Society of Blood Transfusion (ISBT) as systems in the human species where cell-surface antigens—in particular, those on blood cells—are "controlled at a single gene locus or by two or more very closely linked homologous genes with little or no observable recombination between them", [1] and include the common ABO and Rh ...
Patient Blood Management (PBM) [1] [2] [3] is a set of medical practices designed to optimise the care of patients who might need a blood transfusion. Patient blood management programs use an organized framework to improve blood health, thus increasing patient safety and quality of life, reducing costs, and improving clinical outcomes.